Overview of P2 receptors: Possible functions in immune cells

被引:24
作者
Burnstock, G [1 ]
机构
[1] UCL Royal Free & Univ Coll, Sch Med, Auton Neurosci Inst, London NW3 2PF, England
关键词
P2X receptors; P2Y receptors; purinergic signaling; immune system;
D O I
10.1002/ddr.1170
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
P2 nucleotide receptors are subdivided into two families: P2X ionotropic ligand-gated ion channel receptors and P2Y metabotropic G-protein-coupled receptors. Seven subtypes of each family have been cloned and characterized. Immune cells are richly supplied by purinoceptors and there is a dominant presence of P1 (A(2A)), P2X(7), P2Y(1), and P2Y(2) receptors. Their mediating roles include: release of prostanoids and inflammatory cytokines; cell proliferation, growth, differentiation, fusion, and death; chemoattraction; cell adhesion and immuno-endothelial cell interactions; bone remodeling (osteoclasts); platelet aggregation; and wound healing, as well as regulation of immune responses. There is plasticity of P2 receptor expression in immune cells during development and after growing in culture. Examples include: the expression of P2Y(2) receptors in mature, but not developing, monocytes and the decline in P2Y(2) mRNA during monocyte to macrophage maturation. Inflammatory mediators have been shown to upregulate P2X(7) receptors and downregulate P2Y(2) receptors. The possible cellular sources of ATP acting on receptors on immune cells are considered, as well as some other questions about mechanisms involving P2 receptors. Therapeutic strategies for drug developments related to purinergic signaling in immune systems are considered. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 72 条
[1]   PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS [J].
ABBRACCHIO, MP ;
BURNSTOCK, G .
PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) :445-475
[2]   Purinergic signalling: Pathophysiological roles [J].
Abbracchio, MP ;
Burnstock, G .
JAPANESE JOURNAL OF PHARMACOLOGY, 1998, 78 (02) :113-145
[3]   Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells [J].
Adrian, K ;
Bernhard, MK ;
Breitinger, HG ;
Ogilvie, A .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2000, 1492 (01) :127-138
[4]   Increased proliferation rate of lymphoid cells transfected with the P2X7 ATP receptor [J].
Baricordi, OR ;
Melchiorri, L ;
Adinolfi, E ;
Falzoni, S ;
Chiozzi, P ;
Buell, G ;
Di Virgilio, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (47) :33206-33208
[5]   Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases [J].
Berchtold, S ;
Ogilvie, ALJ ;
Bogdan, C ;
Mühl-Zürbes, P ;
Ogilvie, A ;
Schuler, G ;
Steinkasserer, A .
FEBS LETTERS, 1999, 458 (03) :424-428
[6]   Molecular cloning and characterization of rat P2Y4 nucleotide receptor [J].
Bogdanov, YD ;
Wildman, SS ;
Clements, MP ;
King, BF ;
Burnstock, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (03) :428-430
[7]   The expression of P2X3 purinoreceptors in sensory neurons:: Effects of axotomy and glial-derived neurotrophic factor [J].
Bradbury, EJ ;
Burnstock, G ;
McMahon, SB .
MOLECULAR AND CELLULAR NEUROSCIENCE, 1998, 12 (4-5) :256-268
[8]   NEW STRUCTURAL MOTIF FOR LIGAND-GATED ION CHANNELS DEFINED BY AN IONOTROPIC ATP RECEPTOR [J].
BRAKE, AJ ;
WAGENBACH, MJ ;
JULIUS, D .
NATURE, 1994, 371 (6497) :519-523
[9]  
Brown SG, 2000, DRUG DEVELOP RES, V49, P253
[10]   Expanding field of purinergic signaling [J].
Burnstock, G .
DRUG DEVELOPMENT RESEARCH, 2001, 52 (1-2) :1-10